A review of research about Trikafta and mental health: a report from Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health Working Group
Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant
Use of Elexacaftor/Tezacaftor/Ivacaftor in Pregnant Mothers without CF to Treat Meconium Ileus in Fetuses with Cystic Fibrosis
Effect of elexacaftor/tezacaftor/ivacaftor on the use of routine therapies in Danish people with cystic fibrosis
Coping and Learning to Manage Stress (CALM): A telehealth intervention to help reduce depression and anxiety symptoms in adults with CF
Understanding rates of and factors associated with elexacaftor/tezacaftor/ivacaftor (ETI) prescription